Camptothecin analogs conjugated to a glutamine residue in a protein, and their use
NZ835068APending Publication Date: 2026-07-31REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- NZ835068
- Authority / Receiving Office
- NZ · NZ
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-02-26
- Filing Date
- 2021-07-12
- Publication Date
- 2026-07-31
Smart Images

Figure 00000208_0000 
Figure 00000251_0000 
Figure 00000300_0000
Abstract
Described herein are protein-drug conjugates and compositions thereof that are useful, for example, for target-specific delivery of therapeutic moieties, e.g., camptothecin analogs and / or derivatives. In certain embodiments, provided are specific and efficient methods for producing protein-drug constructs (e.g., antibody-drug conjugates) utilizing a combination of transglutaminase and 1,3-cycloaddition techniques. Camptothecin analogs, antibody-drug conjugates, and compositions which comprise glutaminyl-modified antibodies and camptothecin analog payloads and are provided.
Need to check novelty before this filing date? Find Prior Art